Clinical Trials in San Diego

Showing 4161-4180 of 14,220 trials

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

NCT06876571

This protocol describes the pivotal accuracy study for the IdentiClone Dx TRG Assay. The intent of the accuracy study is to demonstrate agreement between the results of the IC TRG Dx Assay and a predicate devise or assay on retrospective and residual de-identified DNA extracted from FFPE (Formalin Fixed Paraffin Embedded) samples from individuals with suspected T-Cell Lymphoproliferations. The predicate device will be the LymphoTrack Dx TRG (FR1/FR2/FR3) Assays - MiSeq (LT Dx TRG-CE-IVD), which is a CE-IVD assay with a similar intended use as the IC TRG Assay on the same sample type.

T-Cell Lymphoproliferative Disorder

Invivoscribe, Inc.250 participantsStarted Jun 2025

San Diego, California, United States • Hallbergmoos, Germany • Kawasaki-shi, Kanagawa, Japan

Active Not RecruitingPhase 3< 1 mile

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

NCT04214834

The objective of this study is to evaluate the efficacy of a rapid wean intervention compared with a slow-wean intervention in reducing the number of days of opioid treatment from the first dose of weaning to cessation of opioid among infants receiving an opioid (defined as morphine or methadone) as the primary treatment for neonatal opioid withdrawal syndrome (NOWS).

Neonatal Opioid Withdrawal Syndrome

Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program189 participantsStarted Sep 2020

Birmingham, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +21 more locations

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Find Trials by Condition in San Diego

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial

A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

Infant Mortality Reduction by the Mass Administration of Azithromycin

Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study

A Study of LY3561774 in Participants With Mixed Dyslipidemia

Brain Injury Rehabilitation Improving the Transition Experience